Paul W. Sheppard
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease 3
- Cellular transport and secretion 3
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 16
- Physiology top 5%
- Alzheimer's disease research and treatments 4
- Neurology top 5%
- Aging top 10%
-
- Cancer-related Molecular Pathways 8
- Bone health and treatments 4
-
- Autophagy in Disease and Therapy 5
-
- Genetics and Neurodevelopmental Disorders 4
- Co-authors
- Robert LayfieldJames R. CaveyMark S. SearleR. John MayerSimon PaineLynn BedfordBarbara CianiStuart H. Ralston
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (2 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Paul W. Sheppard
32 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 110
- Cell Biology 414
- Molecular Biology 1.4k
- Physiology 522
- Neurology 147
- Aging 31
Countries citing papers authored by Paul W. Sheppard
This map shows the geographic impact of Paul W. Sheppard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W. Sheppard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W. Sheppard more than expected).
Fields of papers citing papers by Paul W. Sheppard
This network shows the impact of papers produced by Paul W. Sheppard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W. Sheppard. The network helps show where Paul W. Sheppard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul W. Sheppard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 25 | |
| 2 | 2010 | 82 | |
| 3 | 2010 | 160 | |
| 4 | 2010 | 208 | |
| 5 | 2009 | 34 | |
| 6 | 2008 | 186 | |
| 7 | 2008 | 250 | |
| 8 | 2008 | 22 | |
| 9 | 2008 | 39 | |
| 10 | 2007 | 128 | |
| 11 | 2006 | 63 | |
| 12 | 2004 | 18 | |
| 13 | 2004 | 1 | |
| 14 | 2003 | 108 | |
| 15 | 2003 | 7 | |
| 16 | 2001 | 98 | |
| 17 | 2001 | 33 | |
| 18 | The production and characterisation of monoclonal antibodies to myc, c-erbB-2 and EFG-receptor using a synthetic peptide approach. | 1990 | 5 |
| 19 | 1977 | 24 | |
| 20 | 1966 | 46 |
About Paul W. Sheppard
Paul W. Sheppard is a scholar working on Oncology, Molecular Biology and Cell Biology, having authored 32 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (8 papers), Autophagy in Disease and Therapy (5 papers), Bone health and treatments (4 papers), Alzheimer's disease research and treatments (4 papers), Genetics and Neurodevelopmental Disorders (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Cellular transport and secretion (3 papers). The work is most often cited by research in Cell Biology (414 citations), Molecular Biology (1.4k citations) and Physiology (522 citations). Paul W. Sheppard has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert Layfield, James R. Cavey, Mark S. Searle, R. John Mayer, Simon Paine, Lynn Bedford, Barbara Ciani, Stuart H. Ralston, Ian M. Varndell and Jeroen Roelofs. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.